| 000 | 01203 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516202912.0 | ||
| 264 | 0 | _c20141126 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1365-2982 | ||
| 024 | 7 |
_a10.1111/nmo.12329 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNasser, Y | |
| 245 | 0 | 0 |
_aToward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher". _h[electronic resource] |
| 260 |
_bNeurogastroenterology and motility _cApr 2014 |
||
| 300 |
_a447-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 |
_aAmidohydrolases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAnalgesics _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntidiarrheals _xpharmacology |
| 650 | 0 | 4 |
_aEndocannabinoids _xmetabolism |
| 650 | 0 | 4 |
_aGastrointestinal Motility _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xmetabolism |
| 700 | 1 | _aBashashati, M | |
| 700 | 1 | _aAndrews, C N | |
| 773 | 0 |
_tNeurogastroenterology and motility _gvol. 26 _gno. 4 _gp. 447-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/nmo.12329 _zAvailable from publisher's website |
| 999 |
_c23651071 _d23651071 |
||